Preliminary Program

SCIENTIFIC SESSION I: Stones / Endourology
(5 minute presentation, 3 minute discussion)
Moderators: Peter Steinberg, MD, Piruz Motamedinia, MD

Patient Experience with Tria versus Traditional Ureteral Stents
Daniel Pohl, MD¹, Jessica Mandeville, MD¹, Yixin Kong, PhD¹, Laken Smothers, MPH, BS², William Faust, MD^1
1Lahey Clinic and Medical Center, Burlington, MA, USA, ²Tufts University School of Medicine, Boston, MA, USA

Assessing the safety of ureteral stent placement for obstructive urolithiasis in patients during the covid-19 pandemic
Ankur Ushir Choksi, MD, Soum D. Lokeshwar, MD, Mursal Gardezi, MD, Christopher S. Hayden, MD, Timothy Tran, MD, Dinesh Singh, MD, Piruz Motamedinia, MD, Thomas V. Martin, MD.
Yale School of Medicine, New Haven, CT, USA.

Regional Trends in Potassium Citrate Prescribing Amongst Urologists in the United States
Emma Harwood, MD¹, Evelyn James, MPH¹, Daniel Wollin, MS, MD², David Sobel, MD^1
1Maine Medical Center, Portland, ME, USA, ²Brigham and Women’s Hospital, Boston, MA, USA

Pharmacovigilance Study of Type 1a Selective Alpha Blocker Side Effects in Nephrolithiasis
Jonathan J. Song, BA¹, Quoc-Dien Trinh, MD, MBA², Daniel A. Wollin, MD^3
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA, ²Department of Urology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA, ³Department of Urology, Brigham and Women’s Hospital, Boston, MA, USA

Initial Experience with Single-Port Robot-Assisted Partial Nephrectomy: A Comparison with Multi-Port Partial Nephrectomy
Angela Estevez, MD, Helen W. Cui, BMBS PhD, Gabriela Nieto-Blanco, MS, Jeffrey Sun, BS, Sarah Duncan, BA, Phillip Kim, MD, Adam Nolte, MD, Peter Chang, MD MPH, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA

Single-Probe Dual-Energy Lithotripter Complications: A Law Review and Comprehensive Analysis of the FDA MAUDE Database
Cedrick B. Chiu, BS¹, Orleiquis Guerra, MD¹, Clemens An, BS², Kevan Sternberg, MD^1
1UMass Chan Medical School, Worcester, MA, USA, ²Larner College of Medicine at The University of Vermont, Burlington, VT, USA

Prolonged Antibiotic Exposure Within 90 Days of Percutaneous Nephrolithotomy is Not a Risk Factor for Yeast Growth in Renal Stone Culture
Fern Calkins, B.S.¹, Architha Sudhakar, MD², Evelyn James, M.S.², Erin Santos, PA-C², David W. Sobel, MD^2
1Tufts University School of Medicine, Boston, MA, USA, ²Division of Urology, Maine Medical Center, Portland, ME, USA

Cystinuria: Epidemiology and Management of a Rare Cause of Nephrolithiasis Using a Global Collaborative Network
Nicholas Moll, MD, Vernon Pais, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH, USA

Ureteral Stricture Formation After Use of Ureteral Access Sheaths
Christina Kottooran, MD¹, Jose ECM Rodrigues, MD², Brian H. Eisner, MD¹.
¹Massachusetts General Hospital, Boston, MA, USA, ²Universidade de São Paulo, São Paulo, Brazil.

Senior Slump? The Arc of Ureteroscopy Experience and Trainee Confidence During Residency Training
Loren J. Smith, MD¹, Evelyn James, MPH¹, Vanessa Lukas, MD², Kevan Sternberg, MD³, Daniel Wollin, MD², David Sobel, MD^1
1Division of Urologic Surgery, Maine Medical Center, Portland, ME, USA, ²Department of Urology, Brigham and Women's Hospital, Boston, MA, USA, ³University of Massachusetts Memorial Medical Center, Worcester, MA, USA

STATE OF THE ART LECTURE I: Kidney Cancer, Unmasking the Myths
Alexander Kutikov, MD, FACS
Fox Chase Cancer Center, Philadelphia, PA

PANEL: New Technologies in Urology

FPRMS: Sanchita Bose, MD
Endourology: Ruslan Korets, MD
Men’s Health: Gabby Avellino, MD
Reconstructive Urology: Marissa Kent, MD

SCIENTIFIC SESSION II: Prostate Cancer I
(5 minute presentation, 3 minute discussion)
Moderators: Keyan Salari, MD, Joseph Brito, MD

A Propensity Score Matched Analysis Of Apical Margin Positivity Between Single Port And Multiple Port Robotic Radical Prostatectomies
Ankur Ushir Choksi, MD, Soum D. Lokeshwar, MD, Joseph Renzulli, MD, Joseph Brito, MD, David Hesse, MD, Thomas V. Martin, MD, Preston Sprenkle, MD, Michael Leapman, MD, Isaac Y. Kim, MD PhD MBA
Yale School of Medicine, New Haven, CT, USA

Comparison Of The Incidence Of Clinically Significant Prostate Cancer In Patients With Isolated Peripheral Vs Transitional Zone PIRADS 3 Lesions
Kamil Malshy, MD¹, Anna Ochsner, B.Sc², Rebecca Ortiz, B.Sc¹, Benjamin Ahn, B.Sc², Richard Glebocki, B.Sc¹, Mathew Liu, Mr.¹, Borivoj Golijanin, MD¹, Samuel Eaton, MD¹, Dragan Golijanin, MD¹, Elias Hyams, MD¹, Sari Khaleel, MD^1
1Minimally Invasive Urology Institute, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA, ²Warren Alpert Medical School of Brown University, Providence, RI, USA

Conditional Survival Over Time and Time-Varying Analysis on Active Surveillance for Prostate Cancer
Hersh H. Bendre, MD, Florian Rumpf, MD, Andrew Gusev, MD, Alie Hunter, BA, Aileen Feng, BA, Neel Patel, MBBS, Matthew Wszolek, MD, Douglas Dahl, MD, Adam Feldman, MD, MPH, Keyan Salari, MD, PhD
Massachusetts General Hospital, Boston, MA, USA

Traditional Racial and Sociodemographic Disparities in Prostate Cancer Screening are not Evident in a Large Public Safety-Net Institution
Hanna Zurl, MD¹, Michelle Shabo, MD², Filippo Dagnino, MD¹, Rumel Mahmood, PhD³, Benjamin G. Allar, MD MPH⁴, Boris Gershman, MD², Lisa Weissman, MD⁵, Gezzer Ortega, MD MPH⁶, Stephanie Hastings, DO⁷, Heidi J. Rayala, MD PhD^2
1Department of Urology, Brigham and Women’s Hospital and Center for Surgery and Public Health, Harvard Medical School, Boston, MA, USA, ²Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, ³Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA, ⁴Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, ⁵Department of Hematology/Oncology, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA, ⁶Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, ⁷Department of Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA

The Use of Multiparametric MRI and Fusion Biopsy in Active Surveillance Results in Earlier Identification and Treatment of Clinically Significant Prostate Cancer
Christina Kottooran, MD¹, Hersh Bendre, MD¹, Alice Yu, MD², Andrew Gusev, MD¹, Timothy Baloda, MD³, Eduoard Nicaise, MD⁴, Mukesh Harisinghani, MD¹, Amirkasra Mojtahed, MD¹, Anthony Zietman, MD¹, Douglas M. Dahl, MD¹, Matthew Wszolek, MD¹, Keyan Salari, MD, PhD¹, Adam Feldman, MD, MPH^1
1Massachusetts General Hospital, Boston, MA, USA, ²Moffitt Cancer Center, Tampa, FL, USA, ³Emory Healthcare, Atlanta, GA, USA, ⁴Lenox Hill Hospital, New York, NY, USA

Time Trends and Determinants of Active Surveillance Among Patients with Intermediate Risk Prostate Cancer
Ismail Ajjawi, MD, Vinaik Sundaresan, MD, Shayan Smani, MD, Preston C. Sprenkle, MD, Michael S. Leapman, MD, MHS
Yale School of Medicine, New Haven, CT, USA

Retrospective Comparison Between Transperineal and Transrectal Prostate Biopsy Complications
Alfred A. Barney, IV, B.S.¹, Piroz Bahar, B.S.², Constantine Velmahos, B.S.³, Clemens An, B.S.⁴, Aileen Feng, B.S.¹, Shulin Wu, MD¹, Chin-Lee Wu, MD, Ph.D¹, Michelle Kim, MD, Ph.D¹, Douglas M. Dahl, MD¹, Adam S. Feldman, MD, MPH^1
1Massachusetts General Hospital, Boston, MA, USA, ²University of Michigan Medical School, Ann Arbor, MI, USA, ³University of Massachusetts Chan Medical School, Worcester, MA, USA, ⁴Larner College of Medicine, University of Vermont, Burlington, VT, USA

Racial Differences in Post-Pandemic Trends in Prostate Specific Antigen Screening
Zhiyu (Jason) Qian, MD, Jameshisa Alexander, BS, Danesha Daniels, BS, Firas Abdollah, MD, Alexander P. Cole, MD, Hari Iyer, ScD, Quoc-Dien Trinh, MD, MBA
Brigham and Women's Hospital, Boston, MA, USA

Outcomes Of Men With High-Risk Biochemically Recurrent Prostate Cancer Who Suspended Enzalutamide Monotherapy Treatment In The Phase 3 EMBARK Study
Neal D. Shore, MD, FACS¹, Paul R. Sieber, MD², Ugo De Giorgi, MD, PhD³, Tony Luongo, MD⁴, Bryan A. Mehlhaff, MD⁵, Daniel C. Danila, MD⁶, Curtis J. Dunshee, MD, FACS⁷, Costas D. Lallas, MD⁸, Marc J. Pliskin, MD⁹, Yiyun Tang, PhD¹⁰, Gabriel P. Haas, MD, FACS¹¹, Matt Rosales, PhD¹¹, Jamal Tarazi, MD, MPA¹², Fabian Zohren, MD, PhD¹², David Russell, MD¹⁰, Stephen J. Freedland, MD^13
1Surgical Oncology and Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA, ²Keystone Urology Specialists, Lancaster, PA, USA, ³IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy, ⁴Tufts University School of Medicine, Boston, MA, USA, ⁵Oregon Urology Institute, Springfield, OR, USA, ⁶Memorial Sloan Kettering, New York, NY, USA, ⁷Urological Associates of Southern Arizona, Tucson, AZ, USA, ⁸Jefferson Urology Associates, Philadelphia, PA, USA, ⁹TriState Urologic Services PSC Inc., dba The Urology Group, Cincinnati, OH, USA, ¹⁰Pfizer Inc., New York, NY, USA, ¹¹Global Product Development, Astellas Pharma Inc., Northbrook, IL, USA, ¹²Formerly of Pfizer Inc., New York, NY, USA, ¹³Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA and the Durham VA Medical Center, Durham, NC, USA

Need For Combined Targeted And Systematic Biopsy In Detection Of Clinically Significant Prostate Cancer
Anna M. Ochsner, BS, Kamil Malshy, MD, Rebecca Ortiz, BS, Borivoj Golijanin, BS, Benjamin Ahn, BS, Richard Glebocki, BS, Matthew Liu, BS, Sari Khaleel, MD, Dragan Golijanin, MD, Elias Hyams, MD
Minimally Invasive Urology Institute, Providence, RI, USA

Risk factors for Gleason Upgrading: A Comparison of High-resolution Micro-Ultrasound, Conventional Ultrasound and MRI fusion Biopsy Techniques
Soum D. Lokeshwar, MD, MBA, Ankur U. Choksi, MD, Shayan Smani, BS, Victoria Kong, BS, Vinaik Sundaresan, BS, Joseph Brito, MD, Joseph Renzulli, MD, Preston Sprenkle, MD, Michael S. Leapman, MD MHS
Yale University, New Haven, CT, USA

PAC UPDATE
Arthur Tarantino, MD

SAC UPDATE
Brian Irwin, MD

PUBLIC POLICY COUNCIL UPDATE
Jen Yates, MD

LUNCH SYMPOSIUM
A GnRH Antagonist Treatment Option for Advanced Prostate Cancer
Sponsored by Sumitomo/Pfizer Pharma
Speaker: Christopher M. Pieczonka, MD

LUNCH SYMPOSIUM
Initial and Updated Clinical Data for Certain Patients With RCC in the Adjuvant Setting
Sponsored by Merck
Speaker: Paul Sieber, MD

AMERICAN BOARD OF UROLOGY UPDATE
Ann Gormley, MD

JU UPDATE
Martin Gross, MD

CONCURRENT POSTER SESSION I
(3-minute presentation, 2-minute discussion)
Moderators: Michael Grant, MD, Lauren Bakios, MD

Methylation of SRD5A2 in the Blood as a Novel Biomarker to Predict Sensitivity to 5-ARI Treatment
Ra'ad Al-Faouri, MD MMSc¹, Christina Sharkey, ALM¹, Heidi Rayala, MD, PHD¹, Ruslan Korets, MD¹, Wei Wang, PHD², Zongwei Wang, PHD¹, Mukesh G. Harisinghani, MD³, Leo L. Tsai, MD, PHD³, Aria F. Olumi, MD^1
1Beth Israel Deaconess Medical Center - Harvard Medical School, Boston, MA, USA, ²Brigham and Women's Hospital - Harvard Medical School, Boston, MA, USA, ³Massachusetts General Hospital - Harvard Medical School, Boston, MA, USA

Advancing Minimally Invasive Adrenalectomy: Is There a Benefit of the Robotic-Assisted Single Port Approach?
Angela Estevez, MD, Helen W. Cui, BMBS PhD, Phillip Kim, MD, Adam Nolte, MD, Gabriela Nieto-Blanco, M.S, Jeffrey Sun, B.S, Sarah Duncan, BA, Peter Chang, MD MPH, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA

Evaluating Factors Affecting the Recurrence of Testicular Torsion in a Single New England State
Jacqueline Klepinger, BS¹, Loren Smith, MD¹, Evelyn James, MPH², Lily Wang, MD-PhD^1
1Maine Medical Center, Portland, ME, USA, ²Maine Medical Partners, South Portland, ME, USA

Factors Associated with Outcomes after Pyeloplasty in the Pediatric Population
Olamide Olawoyin, MD, Benjamin Press, MD, Ankur U. Choksi, MD, Robert M. Weiss, MD, FACS, FAAP, Joshua Sterling, MD, MSc, Angela Arlen, MD
Yale New Haven Health, New Haven, VT, USA

A novel technique for perineal urethrostomy derived from urethral reconstruction after penile inversion neovaginoplasty
Samuel Helrich, MD, Ricardo Munarriz, MD
Boston Medical Center, Boston, MA, USA

The Association of Robotic-Assisted versus Open Radical Cystectomy with Real-World Postoperative Morbidity among Older Adults With Bladder Cancer
Joseph B. Black, MD, PHD¹, Sumedh Kaul, MS¹, Aaron Fleishman, MPH¹, Ruslan Korets, MD¹, Peter Chang, MD, MPH¹, Andrew Wagner, MD¹, Simon Kim, MD², Joaquim Bellmunt, MD, PHD³, Nima Aghdam, MD¹, Irving Kaplan, MD¹, Aria F. Olumi, MD¹, Boris Gershman, MD^1
1Beth Israel Deaconess Medical Center, Boston, MA, USA, ²University of Colorado Anschutz Medical Center, Aurora, CO, USA, ³Dana-Farber Cancer Institute, Boston, MA, USA

Evaluating the Surgical Goals of Transgender Male versus Non-Binary Individuals Considering Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS)
Lee K. Brown, BA¹, Linda M. Kinney, MPA², Rebecca L. Butcher, MS, MPH², Rachel A. Moses, MD, MPH^1
1Dartmouth-Hitchcock Clinic, Lebanon, NH, USA, ²The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA

Gender Disparities in Urology Top Doctor Selection
Anna Saltman, MD, MS, Rachel Mann, MD, Lara MacLachlan, MD, Alireza Moinzadeh, MD, Jessica Mandeville, MD
Lahey, Burlington, MA, USA

Bowel Function after Cystectomy - Does Anything Even Matter?
Randie E. White, MD¹, Connor Pelletier, BS², Evelyn James, BA, MPH¹, Joshua Linscott, MD, PhD³, Jeffrey M. Howard, MD, PhD¹, Stephen T. Ryan, MD¹, Matthew H. Hayn, MD¹, Jesse D. Sammon, DO^1
1Maine Medical Center, PORTLAND, ME, USA, ²University of New England School of Osteopathic Medicine, Biddeford, ME, USA, ³Moffitt Cancer Center, Tampa, FL, USA

Progression on Active Surveillance is Low in Men with PSA Density <0.15 Or Absence of Cancer in MRI-Identified Lesions
Lindsey T. Webb, BSME, Gabriela M. Diaz, MD, Syed N. Rahman, MD, Ghazal Khajir, MD, Preston C. Sprenkle, MD
Yale School of Medicine, New Haven, CT, USA

Assessing the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Transperineal Prostate Biopsy
Dylan M. Buller, MD¹, William Martin, BS², Benjamin Rosenfeld, MD², Amanda Sherman, MD³, William C. Faust, MD³, Serge Ginzburg, MD⁴, Joseph R. Wagner, MD⁵, Andres F. Correa, MD⁶, Kevin Pinto, BS⁵, Peter C. Albertsen, MD¹, Alexander Kutikov, MD⁶, Benjamin T. Ristau, MD, MHA^1
1UConn Health, Farmington, CT, USA, ²University of Connecticut School of Medicine, Farmington, CT, USA, ³Lahey Hospital and Medical Center, Burlington, MA, USA, ⁴Jefferson Einstein Hospital, Philadelphia, PA, USA, ⁵Hartford Healthcare Medical Group, Hartford, CT, USA, ⁶Fox Chase Cancer Center, Philadelphia, PA, USA

Can Magnetic Resonance Imaging Predict Progression of Disease for Patients on Active Surveillance and Impact Biopsy Timing?
Syed N. Rahman, MD, Lindsey T. Webb, BSME, Gabriela M. Diaz, MD, Ghazal Khajir, MD, Soum D. Lokeshwar, MD, Preston C. Sprenkle, MD
Yale School of Medicine, New Haven, CT, USA

CONCURRENT SCIENTIFIC SESSION III: Trauma, Recon, Female Urology and Transgender
(5 minute presentation, 3-minute discussion)
Moderators: Rachel Moses, MD, Mary Grey Maher, MD

Development of a Co-Designed Web-Based Decision Aid for Metoidioplasty and Phalloplasty Gender Affirming Surgeries
Rachel A. Moses, MD, MPH¹, Lee K. Brown, BA¹, Rebecca L. Butcher, MS, MPH², Linda M. Kinney, MPA³, Gaines Blasdel, BS⁴, Jeremy B. Myers, MD⁵, John F. Nigriny, MD¹, Glyn Elwyn, MD, PhD, MSc^6
1Dartmouth-Hitchcock Clinic, Lebanon, NH, USA, ²The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute, Geisel School of Medicine at Dartmouth College, Geisel, NH, USA, ³The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA, ⁴University of Michigan Medical School, Ann Arbor, MI, USA, ⁵University of Utah, Salt Lake City, UT, USA, ⁶The Coproduction Laboratory, The Dartmouth Institute, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA

6-Month Interim Results of a Phase 4, Real-World Study (COMPOSUR) to Evaluate Vibegron in Patients With Overactive Bladder
Michael J. Kennelly, MD¹, Roger R. Dmochowski, MD², Eric S. Rovner, MD³, Diane K. Newman, DNP, ANP-BC⁴, Keith Xavier, MD⁵, Jingmei Lu, MS⁶, Daniel Snyder, PhD⁶, Laleh Abedinzadeh, MD^6
1Carolinas Medical Center, Charlotte, NC, USA, ²Vanderbilt University Medical Center, Nashville, TN, USA, ³Medical University of South Carolina, Charleston, SC, USA, ⁴Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, ⁵Urology Partners of North Texas, Arlington, TX, USA, ⁶Sumitomo Pharma America, Inc., Marlborough, MA, USA

Comparing Lifespan of Virgin Artificial Urinary Sphincters in Radiated Patients: Transcorporal vs. Standard Placement
Kamil Malshy, MD¹, Siddharth Marthi, MD², Rebecca Ortiz, B.Sc¹, Edouard Nicaise, MD², Borivoj Golijanin, B.Sc¹, Kennon Miller, MD¹, Lindsey Hartsell, M.D², Madeline Cancian, MD^1
1Minimally Invasive Urology Institute, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA, ²Department of Urology, Emory University Hospital, Atlanta, GA, USA

Exploring Radiation Cystitis Diagnosis and Management Including Hyperbaric Oxygen Therapy: A Survey of Reconstructive Urologists Practice Patterns
Richard Hans Bellemare, MD¹, Lee K. Brown, BA¹, William Bihrle, III, MD¹, Jeremy B. Myers, MD², Jay C. Buckey, Jr., MD³, Jill C. Buckley, MD⁴, Rachel A. Moses, MD, MPH^1
1Dartmouth Health, Section of Urology, Department of Surgery, Lebanon, NH, USA, ²University of Utah, Division of Urology, Department of Surgery, Salt Lake City, UT, USA, ³Dartmouth Health, Section of Hyperbaric Medicine, Department of Medicine, Lebanon, NH, USA, ⁴UC San Diego Health, Department of Urology, San Diego, CA, USA

Comparison of Surgical Complication Rates in Combined Hysterectomy and Masculinizing Gender Affirming Bottom Surgery Versus Staged Approach: A National Analysis
Marissa Kent, MD, Oluwaseun Adebagbo, BS, John Park, PharmD, Macie Gettings, BS, Sasha Nickman, BS, Benjamin Rahmani, BS, Ryan Cauley, MD, PhD
Beth Israel Deaconess Medical Center, Boston, MA, USA

Fournier Gangrene Registry: Outcomes of a Single Center Over a Decade
Jessica DeLong, MD¹, Sean Elliott, MD², Ramon Virasoro, MD^3
1MultiCare Urology, Puyallup, WA, USA, ²University of Minnesota, Minneapolis, MN, USA, ³Eastern Colorado VA, Colorado Springs, CO, USA

Downregulated Genes Targeted By Microrna In Lichen Sclerosus Urethral Strictures
Samantha Freeman, MD, Rachael Gotlieb, MD, Kailey Hooper, BS, Travis Sullivan, MS, Aaron Perecman, MD, Anna Saltman, MD, Kimberly Rieger-Christ, PhD, Alex Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA, USA

GUEST SPEAKER: Advanced Robotic Techniques including SP Platform
Peter Chang, MD
Beth Israel Deaconess Medical Center, Boston, MA

DEBATE: TP vs Transrectal Biopsy
Moderator: Bill Faust, MD
Ben Ristau, MD vs. Francis McGovern, MD

“MARKET DYNAMICS: BIG BUSINESS COMING FOR HEALTHCARE?"
Ruchi Talwar, MD
Vanderbilt University Medical Center, Nashville, TN

BREAKFAST SYMPOSIUM
Treatment Intensification with XTANDI (Enzalutamide) for Patients with Metastatic Castration-Sensitive Prostate Cancer & Nonmetastatic Castration-Sensitive Prostate Cancer with Biochem Recurrence at High Risk for Metastasis
Sponsored by Astellas
Speaker: Gordon Brown, DO, FACOS
Urologic Surgery, Rowan University School of Osteopathic Medicine
Delaware Valley Urology; Kennedy University Hospital

Learn Indications and proper preparation techniques for cystoscopy
Shireen Kirata PA-C

Acquire knowledge of step-by-step mechanical sequence for completion of diagnostic cystoscopy and cysto/stent pull
Dr. Manganiello

Become familiar with common cystoscopic findings
Dr. Zbrezny

Gain knowledge on how to roll out into AP practice
Dr. Stacy DiPerna ACNP

Pelvic Floor and So Much More
Jill Cramp, PT, DPT, PRPC

CONCURRENT SCIENTIFIC SESSION IV: General/BPH
(5 minute presentation, 3 minute discussion)
Moderators: Heidi Rayala, MD, Michael Grant, MD

Bladder Function and Safety of Vibegron in Men With Symptoms of Overactive Bladder and Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial
Eric Rovner, MD¹, Janet Owens-Grillo, PhD, MS², Elizabeth Thomas, MS², Sender Herschorn, MD³, Kenneth Peters, MD⁴, David Staskin, MD⁵, Kevin Cline, MD⁶, Salim Mujais, MD².
¹Medical University of South Carolina, Charleston, SC, USA, ²Sumitomo Pharma America, Inc., Marlborough, MA, USA, ³Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, ⁴Oakland University William Beaumont School of Medicine, Rochester, MI, USA, ⁵Tufts University School of Medicine, Boston, MA, USA, ⁶Louisiana State University Health, Shreveport, LA, USA

An Analysis of Reoperations for Benign Prostatic Hyperplasia from a Near Real Time Live Dataset- TriNetX
Clemens An, BS¹, Benjamin Rubin, BS¹, Jake Jeong, BS², Richard Grunert, MD FACS^1
1University Of Vermont, Burlington, VT, USA, ²Washington University School of Medicine, St. Louis, MO, USA

Review of an Acute Care Urology Model at a Large Tertiary Academic Medical Center
Akshay G. Reddy, MD, Jeffrey S. Lamont, MD, Michelle Kim, MD, PhD, Marc D. Manganiello, MD
Massachusetts General Hospital, Boston, MA, USA

Medication-Induced Acute Urinary Retention: Insights from FDA Pharmacovigilance Database
Cedrick B. Chiu, BS¹, Orleiquis Guerra, MD¹, Jennifer Anger, MD, MPH², Kevan Sternberg, MD^1
1UMass Chan Medical School, Worcester, MA, USA, ²UC San Diego Medical Center, La Jolla, CA, USA

Can Artificial Intelligence Promote Equity in Urologic Care?
Loren J. Smith, MD, Evelyn James, MPH, Bruce T. Ndebanje, B.S., Lily C. Wang, MD, PhD
Division of Urologic Surgery, Maine Medical Center, Portland, ME, USA

Does Urine Culture Before Endoscopic Prostate Surgery Decrease Postoperative Urinary Tract Infection? An Analysis of the Veterans Affairs Surgical Quality Improvement Program
Muhieddine Labban, MD¹, William J. O'Brien, MS², Kalpana Gupta, MD, MPH², Lori Lerner, MD^2
1Brigham and Women's Hospital, Boston, MA, USA, ²Veteran Affairs Boston Healthcare System, Boston, MA, USA

Diagnostic Features and Management Outcomes of Torsion-Detorsion
Olamide Olawoyin, MD, Ankur Choksi, MD, Nishan Sohoni, BSc, Benjamin Press, MD, Angela Arlen, MD
Yale New Haven Health, New Haven, CT, USA

VIDEO ABSTRACT SESSION
(5 Minutes Videos, 4 Minute Discussion)
Moderators: Andrew Wagner, MD, Jennifer Fantasia, MD

Robotic Radical Nephrectomy with IVC Tumor Thrombectomy
Keyan Salari, MD, PhD
Massachusetts General Hospital, Boston, MA, USA
View Video

Low Anterior Access for Retroperitoneal Single-Port Robotic Pyeloplasty
Angela Estevez, MD, Phillip Kim, MD, Suprita Krishna, MD, Helen W. Cui, BMBS PhD, Gabriela Nieto-Blanco, MS, Jeffrey Sun, BS, Sarah Duncan, BA, Adam Nolte, MD, Andrew A. Wagner, MD, Peter Chang, MD MPH
Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video

Single Port Robotic Assisted Adrenalectomy - Is It Worth It?
Helen W. Cui, BMBS PhD, Angela Estevez, MD, Jeffrey Sun, Gabriela Nieto-Blanco, Phillip Kim, MD, Sarah Duncan, Adam Nolte, MD, Peter Chang, MD, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video

Single-Port Robotic Intravesical Diverticulectomy
Sina Monfared, MD, Suprita Krishna, MD, Peter Chang, MD
Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video

Intussusception Technique for Accessing The Renal Pelvis Through a Narrow Infundibulum With Mini-PCNL
Clark Judge, Piruz Motamedinia
Yale, New Haven, CT, USA
View Video

Modern Techniques to Increase Stone Free Rates
Daniela Diaz Rubayo, MD, Xinyue C. Tan, MD, Isaac Bronson, Katherine Merport, Brielle Barclay, Kevan Sternberg, MD, Igor Sorokin, MD
UMass Chan Medical School, Worcester, MA, USA
View Video

Novel Use of the Piranha Morcellator To Evacuate Fungal Debri Within the Bladder
Dylan Heckscher, Ankur Ushir Choksi, MD, Ellen Cahill, Jason Lee, Daniel Kellner
Yale School of Medicine, New Haven, CT, USA
View Video

Successes and Cautions of JELMYTO Instillation for Upper Tract Urothelial Carcinoma
Chandler Bronkema, Brian Eisner, Adam Feldman
Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
View Video

Bulkamid Injection for Recurrent Post-Prostatectomy Stress Incontinence in a Male Patient
Philip Olson, MD¹, Shanta Shepherd, MD^2
1University of Connecticut, Farmington, CT, USA, ²Saint Francis Hospital, Hartford, CT, USA
View Video

ProTouch Laser Enucleation of the Prostate (ProLEP): Procedure Video
Maya T. Zhou, BS¹, Melissa Huang¹, Evan Sheh¹, Michael Emmerling, MD¹, Wesley Pate, MD¹, Shaun E. L. Wason, MD^2
1Boston University, Boston, MA, USA, ²Beth Israel Deaconess Medical Center, Boston, MA, USA
View Video

CONCURRENT POSTER SESSION II
(3 minute presentation, 2 minute discussion)
Moderators: Jaime Cavallo, MD

Patient-reported Toxicity During Intravesical Therapy for Non-Muscle Invasive Bladder Cancer
Matthew Clements, MD, MS¹, Nicole Liso, BS², Benjamin Seiden, MD³, Alvin Goh, MD², Timothy Donahue, MD², Bernard Bochner, MD², Eugene Pietzak, MD^2
1Lahey Hospital & Medical Center, Burlington, MA, USA, ²Memorial Sloan Kettering Cancer Center, New York, NY, USA, ³SUNY Downstate, New York, NY, USA

A Framework for Categorizing Bottom Dysphoria in Transgender and Nonbinary Patients
Hunter R. Myers, BA¹, Neeki Parsa, BA¹, Urszula Kowalik, MD^2
1Larner College of Medicine, Burlington, VT, USA, ²University of Vermont Medical Center, Burlington, VT, USA

Fournier Gangrene Registry: Outcomes of a Single Center Over a Decade
Andres H. Guillen Lozoya, MD, Luqman Ellythy, MS, Alexander Krueger, MS, Katherine Anderson, MD, Sevann Helo, MD
Mayo Clinic, Rochester, MN, USA

Exploring Urine Inflammatory Biomarkers Pre and Post Hyperbaric Oxygen Therapy for Radiation Cystitis Following Prostate Cancer: A Pilot Study
Richard Hans Bellemare, MD¹, Daniel Mielcarz, PhD², Ziyin Zhang, MS³, Eugene Demidenko, PhD⁴, Bassem Zaki, MD⁵, William Bihrle, III, MD¹, Jay C. Buckey, Jr., MD⁶, Rachel A. Moses, MD, MPH^1
1Dartmouth Health, Section of Urology, Department of Surgery, Lebanon, NH, USA, ²DartLab, Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, NH, USA, ³Giesel School of Medicine at Dartmouth, Lebanon, NH, USA, ⁴Dartmouth Health, Dartmouth Cancer Center, Giesel School of Medicine at Dartmouth, Lebanon, NH, USA, ⁵Dartmouth Health, Section of Radiation Oncology, Department of Medicine, Lebanon, NH, USA, ⁶Dartmouth Health, Section of Hyperbaric Medicine, Department of Medicine, Lebanon, NH, USA

Timing Considerations for Artificial Urinary Sphincter Implantation Post-Pelvic Radiotherapy
Kamil Malshy, M.D¹, Siddharth Marthi, MD², Edouard Nicaise, MD², Borivoj Golijanin, MD¹, Kennon Miller, MD¹, Lindsey Hartsell, MD², Madeline Cancian, MD^1
1Minimally Invasive Urology Institute, The Warren Alpert Medical School of Brown University, Providence, RI, USA, ²Department of Urology, Emory University Hospital, Atlanta, GA, USA

First Safety and Efficacy Results of the TAR-210 Erdafitinib Intravesical Delivery System in Patients with Non-Muscle-Invasive Bladder Cancer with Select FGFR Alterations
Joseph M. Jacob, MD¹, Antoni Vilaseca, MD², Gautam Jayram, MD³, Carles Raventos, MD⁴, Neal D. Shore, MD⁵, Daniel Zainfeld, MD⁶, Taek Won Kang, MD⁷, Ja Hyeon Ku, MD⁸, Joshua Meeks, MD⁹, Óscar Rodríguez Faba, MD¹⁰, Florian Roghmann, MD¹¹, Siamak Daneshmand, MD¹², Neil Beeharry, MD¹³, Carrye R. Cost, MD¹³, Anna Kalota, MD¹³, Josh Lauring, MD¹³, Michelle R. Peterson, MD¹⁴, Michelle Quiroz, MD¹³, Nicole L. Stone, MD¹³, Wei Zhu, MD¹⁴, Felix Guerrero-Ramos, MD^15
1Department of Urology, Syracuse, NY, USA, ²Hospital Clínic de Barcelona, Barcelona, Spain, ³Urology Associates, Nashville, TN, USA, ⁴Department of Urology, Vall d'Hebron, Barcelona, Spain, ⁵Carolina Urologic Research Center, Myrtle Beach, SC, USA, ⁶Urology San Antonio, San Antonio, TX, USA, ⁷Department of Urology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea, Democratic People's Republic of, ⁸Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Democratic People's Republic of, ⁹Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA, ¹⁰Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain, ¹¹Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany, ¹²Department of Urology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA, ¹³Janssen Research & Development, Spring House, PA, USA, ¹⁴Janssen Research & Development, Raritan, NJ, USA, ¹⁵University Hospital ¹² de Octubre, Madrid, Spain

Defining Success in Pyeloplasty Patients to Guide Initial Postoperative Followup
Jane Renee Kielhofner, BS¹, Jonathan Song, B.S.², Zhiyu Qian, MD¹, Catherine Gu, MD¹, William Boysen, MD¹, Steven L. Chang, MD¹, Douglas M. Dahl, MD³, Eswara Jairam, MD⁴, George Haleblian, MD¹, Anton Wintner, MD³, Daniel Wollin, MD^1
1Brigham and Women's Hospital, Boston, MA, USA, ²Boston University Medical School, Boston, MA, USA, ³Massachusetts General Hospital, Boston, MA, USA, ⁴St. Elizabeth Medical Center Department of Urology, Brighton, MA, USA

Surgical Management of Ureteral Complications of Kidney Transplantation
Andrea Sorcini, MD, Samantha Freeman, MD, Alireza Moinzadeh, MD, Julia Hall, BA, Max S. Lohse, BA
Lahey Health, Burlington, MA, USA

The Hospital Price Transparency Rule in USNWR Ranked Hospitals- Differences in Price and Disclosure in Urologic Procedures Compared to Mammography
Anna M. Ochsner, BS, Borivoj Golijanin, BS, Justin Bessette, BS, Angelo Blancaflor, BS, Aaron Cleofas, BS, Richard Glebocki, BS, Alexandra Lee, BS, Christopher Tucci, MS, RN-BC, Elias Hyams, MD, Gyan Pareek, MD
Minimally Invasive Urology Institute, Providence, RI, USA

KSP by Degree: A Comparison of Patient Satisfaction with Counseling for Kidney Stone Prevention by Physician versus Advanced Practice Provider
Erin Santos, PA, MPH, MS¹, Loren Smith, MD², Evelyn James, MPH¹, Jesse D. Sammon, DO², David Sobel, MD^2
1Maine Medical Partners Urology, South Portland, ME, USA, ²Maine Medical Center, Portland, ME, USA

Effect of Vibegron on Quality of Life in Men with Benign Prostatic Hyperplasia and Symptoms of Overactive Bladder: Patient-Reported Outcomes From the Phase 3 Randomized Controlled COURAGE Trial
David Staskin, MD¹, Janet Owens-Grillo, PhD, MS², Elizabeth Thomas, MS², Sender Herschorn, MD³, Kenneth Peters, MD⁴, Eric S. Rovner, MD⁵, Kevin Cline, MD⁶, Salim Mujais, MD^2
1Tufts University School of Medicine, Boston, MA, USA, ²Sumitomo Pharma America, Inc., Marlborough, MA, USA, ³Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, ⁴Oakland University William Beaumont School of Medicine, Rochester, MI, USA, ⁵Medical University of South Carolina, Charleston, SC, USA, ⁶Louisiana State University Health, Shreveport, LA, USA

Anticoagulant and Antiplatelet Medications and their Association with Hematuria-Related Complications: A Five-Year Single-Institution Retrospective Study
Joshua Hayden, MD, Jason Nelson, MPH, Edward Frankenberger, BS, Alex Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA, USA

Prior Radiation Therapy is Associated with Increased Risk of Intra-Operative Complications in Patients Undergoing Primary Inflatable Penile Prosthesis Placement: Results from a Large Multi-Institutional Collaborative
Vikram S. Lyall, MD¹, Thomas Alvermann, BS¹, James Jones, MD², Britney Atwater, MD¹, Zafardjan Dalimov, MD³, Linley Diao, MD³, David Barham, MD⁴, Hossein Sadeghi-Nejad, MD⁵, Robert Andrianne, MD⁶, Maxime Sempels, MD⁶, Tung-Chin Hsieh, MD⁷, Georgios Hatzichristodoulou, MD⁸, Muhammad Ammad, MD⁴, Daniar Osmonov, MD⁹, Aaron Lentz, MD¹⁰, Paul Perito, MD¹¹, Alfredo Suarez-Sarmiento, MD¹¹, James Hotaling, MD¹², Koenraad van Renterghem, MD¹³, Sung Hun Park, MD¹⁴, Arthur Burnett, MD¹⁵, Jonathan Nicholas, MD¹⁶, Martin Gross, MD¹, Faysal Yafi, MD⁴, Jay Simhan, MD^3
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, ²Boston University Medical Center, Boston, MA, USA, ³Fox Chase Cancer Center, Philadelphia, PA, USA, ⁴University of California Irvine, Irvine, CA, USA, ⁵NYU Grossman School of Medicine, New York, NY, USA, ⁶Centre Hospitalier Universitaire de Liege, Liege, Belgium, ⁷University of California, San Diego, La Jolla, CA, USA, ⁸'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany, ⁹University Hospital Schleswig Holstein, Kiel, Germany, ¹⁰Duke University, Durham, NC, USA, ¹¹Perito Urology, Coral Gables, FL, USA, ¹²University of Utah, Salt Lake City, UT, USA, ¹³Jessa Hospital, Hasselt, Belgium, ¹⁴Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Democratic People's Republic of, ¹⁵Johns Hopkins Hospital, Baltimore, MD, USA, ¹⁶Mayo Clinic, Rochester, MN, USA

The Effects of Pretreatment with Xiaflex on Penile Curvature Correction with Manual Modeling During and After IPP placement
Britney L. Atwater, MD¹, Richard H. Bellemare, MD¹, Vikram Lyall, MD¹, Thomas Alvermann, BS¹, J. Andrew Jones, MD², Martin S. Gross, MD^1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, ²Boston Medical Center, Boston, MA, USA

Is a Fresh Semen Analysis necessary for a Post Vasectomy Semen Analysis?: Assessment of Stability of Sperm Concentration over a 10-day Time Frame as a Model for Post Vasectomy Semen Analysis Using the Fellow System
Katherine Rotker, MD¹, Sharath Reddy, MD¹, Andrew Fernandez, CLS², Terri Schroeder, CLS², Inderpreet Kaur, CLS², Elsa Chen, CLS², Andre Belarmino, MD³, Akanksha Mehta, MD⁴, Daniel Civello, CLS², Stacey Kenfield, ScD⁵, Stacey Kenfield, ScD⁵, Daniel Nolte, MS², James F. Smith, MD⁵, Stanton Honig, MD^1
1Yale School of Medicine, New Haven, CT, USA, ²Fellow Health, San Leandro, CA, USA, ³UCLA Medical Center, Los Angeles, CA, USA, ⁴Emory University, Atlanta, GA, USA, ⁵UCSF, San Francisco, CA, USA

A Review of Salvage Protocol and Techniques for Penile Prosthesis Infection
Shilpa P. Argade, MD, Karim Hanna, MD, Ricardo Munarriz, MD
Boston Medical Center, Boston, MA, USA

Could My Men’s Health Patient be Considering Self Harm? Outpatient Urology Suicide Risk Assessment with the PHQ-9
Bethany Buckridge, RN, MSN¹, Andrew Kehm, BS², Ilene Staff, PhD³, Tara McLaughlin, PhD¹, Jared Bieniek, MD^1
1Hartford HealthCare, Hartford, CT, USA, ²Frank H. Netter MD School of Medicine, North Haven, CT, USA, ³Hartford Hospital, Hartford, CT, USA

New Findings Regarding Predictors of Patient Progression to Successful Surgical Management of Idiopathic Chronic Orchialgia
Daniela Orozco Rendon, BS¹, Kathryn McGonagle, BA¹, Martin S. Gross, MD^2
1Geisel SOM at Dartmouth, Hanover, NH, USA, ²Dartmouth Health, Hanover, NH, USA

LEADBETTER LECTURE
To Spare or Not to Spare: Expanding the Role of Bladder Preservation for Muscle Invasive Bladder Cancer
Cheryl T. Lee, MD
The Ohio State University, Columbus, OH

RESEARCH UPDATE: The Biology of Aging
Iman Al-Naggar, PhD
University of Connecticut, Farmington, CT

LUNCH SYMPOSIUM
DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Sponsored by Sumitomo Pharma America
Speaker: Jeffrey Frankel, MD Medical Director/Urologist Seattle Urology Research Center

LUNCH SYMPOSIUM
PYLARIFY® (piflufolastat F 18) Injection: Injection PET Imaging in Prostate Cancer Patients: A CASE-BASED REVIEW
Sponsored by Lantheus
Speaker: Munir Ghesani, MD

DEI Committee Update
Jamie Cavallo, MD

PRESIDENTIAL ADDRESS
A Look Under the Hood
Gregory Adey, MD
Fore River Urology, South Portland, ME

SCIENTIFIC SESSION V: Infertility, Sexual Dysfunction and Men’s Health
(5 minute presentation, 3 minute discussion)
Moderators: Martin Kathrins, MD, Gabriella Avellino, MD

In-House Embryology Laboratories Can Prevent Bilateral MicroTESE and Improve Patient Outcomes
Sai Allu, BA¹, Rachel Greenberg, MD², Emily Barry, MD², Gabriella Avellino, MD², Mark Sigman, MD^2
1Warren Alpert Medical School, Providence, RI, USA, ²Brown University Department of Urology, Providence, RI, USA

Posthumous Sperm Retrieval: Survey of Knowledge of Intensive Care Unit Providers
Christopher S. Hayden, MD¹, Victoria Kong, B.S.¹, Shyoko Honiden, MD², Stanton Honig, MD¹, Katherine Rotker, MD^1
1Yale School of Medicine, Department of Urology, New Haven, CT, USA, ²Yale School of Medicine, Department of Medicine (Pulmonary, Critical Care and Sleep Medicine), New Haven, CT, USA

Prior Intracavernosal Injection Therapy is Associated with Intraoperative and Postoperative Complications Attributable to Poor Corporal Integrity in Patients Undergoing Inflatable Penile Prosthesis Placement
James M. Jones, MD¹, Britney Atwater, MD², Vikram Lyall, MD², Thomas Alvermann, BA³, David Barham, MD⁴, Jay Simhan, MD⁵, Faysal Yafi, MD⁴, Martin S. Gross, MD^2
1Boston Medical Center, Boston, MA, USA, ²Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, ³Geisel School of Medicine at Dartmouth, Hanover, NH, USA, ⁴University of California Irvine, Orange, CA, USA, ⁵Fox Chase Cancer Center, Philadelphia, PA, USA

Emerging Data Regarding Predictors of Patient’s Response to Spermatic Cord Block for Idiopathic Chronic Orchialgia
Daniela Orozco Rendon, BS¹, Kathryn McGonagle, BA¹, Martin S. Gross, MD².
¹Geisel SOM at Dartmouth, Hanover, NH, USA, ²Dartmouth Health, Hanover, NH, USA

New Findings Regarding the Degree of Penile Curvature Correction with IPP Alone
Britney L. Atwater, MD¹, Richard H. Bellemare, MD¹, Thomas Alvermann, BS¹, J. Andrew Jones, MD², Vikram Lyall, MD¹, Martin S. Gross, MD^1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, ²Boston Medical Center, Boston, MA, USA

Klinefelter Syndrome: A Review Of Presentation And Fertility Management In A Large Single Practice Cohort
Jessa Willa Sahl, MD, Shilpa Argade, MD, Robert Oates, MD
Boston Medical Center, Boston, MA, USA

Differential Gene Expression in the Tunica Albuginea Tissue of Patients with and without Peyronie’s Disease
Joshua Hayden, MD, Samantha Freeman, MD, Carmen Perrino, MD, Kailey Hooper, BS, Travis Sullivan, MS, Kimberly Rieger-Christ, PhD, Alex Vanni, MD
Lahey Hospital and Medical Center, Burlington, MA, USA

Body Mass Index and Complication Profiles in Patients Undergoing Inflatable Penile Prosthesis Placement: A Large Multi-Institutional Study
Vikram S. Lyall, MD¹, Thomas Alvermann, BS¹, Britney Atwater, MD¹, Muhammad Ammad, MD², David Barham, MD², Nikolaos Pyrgidis, MD, MSc, PhD³, Eliad Amini, MD², Jake Miller, MD², Robert Andrianne, MD⁴, Hossein Sadeghi-Nejad, MD⁵, Kelli Gross, MD⁶, Georgios Hatzichristodoulou, MD⁷, James Hotaling, MD⁶, Tung-Chin Hsieh, MD⁸, Aaron Lentz, MD⁹, Vaibhav Modgil, MD¹⁰, Daniar Osmonov, MD¹¹, Sung Hun Park, MD¹², Faysal Yafi, MD², Paul Perito, MD¹³, Jay Simhan, MD¹⁴, Koenraad van Renterghem, MD¹⁵, Martin Gross, MD¹.
¹Dartmouth Hitchcock Medical Center, Lebanon, NH, USA, ²University of California Irvine, Irvine, CA, USA, ³Ludwig-Maximilians-University of Munich, Munich, Germany, ⁴Centre Hospitalier Universitaire de Liege, Liege, Belgium, ⁵NYU Grossman School of Medicine, New York, NY, USA, ⁶University of Utah, Salt Lake City, UT, USA, ⁷'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany, ⁸University of California, San Diego, La Jolla, CA, USA, ⁹Duke University, Durham, NC, USA, ¹⁰Manchester Andrology Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom, ¹¹University Hospital Schleswig Holstein, Kiel, Germany, ¹²Sewum Prosthetic Urology Center of Excellence, Seoul, Korea, Democratic People's Republic of, ¹³Perito Urology, Coral Gables, FL, USA, ¹⁴Fox Chase Cancer Center, Philadelphia, PA, USA, ¹⁵Jessa Hospital, Hasselt, Belgium

Mail-In Semen Analysis Vs Fresh Sample For Post-Vasectomy Semen Analysis (PVSA): Identifying An Efficient Approach To Achieving Post-Vasectomy Clearance
Katherine Rotker, MD¹, Daniel Nolte, MS², Stacey A. Kenfield, ScD³, Andre Belarmino, MD⁴, Daniel Civello, BS², James F. Smith, MD², Stanton Honig, MD^5
1Yale School of Medicine, New London, CT, USA, ²Fellow Health, San Leandro, CA, USA, ³University of California San Francisco, San Francisco, CA, USA, ⁴UCLA Medical Center, Los Angeles, CA, USA, ⁵Yale School of Medicine, New Haven, CT, USA

CONCURRENT RESIDENT QUIZ BOWL
Facilitator: Michael T. Grant, MD

SUO Lecture: A Personalized and Pragmatic Approach to Prehabilitation
Sarah Psutka, MD
Massachusetts General Hospital, Boston, MA

YOUNG UROLOGIST FORUM: Defining Early Career “Success”
Moderator: Phil Olson, MD

Panel Discussion (25 min)

Academic Practice
Jamie Cavallo, MD
Yale Medicine

Healthcare System Employed (affiliated with residency)
Jared Bieniek, MD
Hartford Healthcare

Other
Joseph McQuaid, MD, MBA
Aura Bio Sciences

EMR Efficiency: Tips and Tricks (20 min)
David Canes, MD

WOMEN IN UROLOGY: Speed Mentoring
Sponsored by Sumitomo Pharma America
Lara MacLachlan, MD
SIGN UP TO BE A MENTOR OR MENTEE

PRESIDENTIAL CELEBRATION
The Graduate Hotel

Prostate Cancer Screening and diagnosis for the APP
Presenter: Erin Santos, PA-C

Urethral Stricture Update for APP
Presenter: Alex Vanni, MD

Urodynamics: Introduction
Presenter: Joel Lee, PA-C

Transgender Care for the APP
Presenter: Khushabu Kasabwala, MD

Sex Therapist
Presenter: Michele Waldron, Psy.D, LADC-I, CSCT

SCIENTIFIC SESSION VI: Bladder/Kidney Cancer (5 minute presentation, 3 minute discussion)
Moderators: Matthew Hayn, MD
Patrick Kenney, MD

TAR-200 in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the SunRISe-1 Study
Joseph Jacob, MD¹, Andrea Necchi, MD², Siamak Daneshmand, MD³, Giuseppe Simone, MD⁴, Evanguelos Xylinas, MD⁵, David S. Morris, MD⁶, Philipp Spiegelhalder, MD⁷, Daniel Zainfeld, MD⁸, Taek Won Kang, MD⁹, Justin T. Matulay, MD¹⁰, Laurence H. Belkoff, MD¹¹, Karel Decaestecker, MD¹², Harm Arentsen, MD¹³, Shalaka Hampras, PhD¹⁴, Chrsitopher J. Cutie, MD¹⁵, Hussein Sweiti, MD¹⁶, Katharine Stromberg, PhD¹⁴, Jason Martin, MD¹⁷, Abhijit Shukla, MD¹⁵, Michiel S. van der Heijden, MD^18
1Department of Urology, Upstate Medical University, Syracuse, NY, USA, ²IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Mialn, Italy, ³Department of Urology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA, ⁴Department of Urology, 'Regina Elena' National Cancer Institute, Rome, Italy, ⁵Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France, ⁶Urology Associates, Nashville, TN, USA, ⁷Urologie Neandertal, Gemeinschaftspraxis für Urologie, Mettmann, Germany, ⁸Urology San Antonio, San Antonio, TX, USA, ⁹Department of Urology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea, Republic of, ¹⁰Atrium Health Levine Cancer Institute, Charloette, NC, USA, ¹¹MidLantic Urology/Solaris Health, Bala Cynwyd, PA, USA, ¹²Department of Urology, AZ Maria Middelares, Ghent, Belgium, ¹³AZ Sint-Jan Hospital Brugge-Oostende, Bruges, Belgium, ¹⁴Janssen Research & Development, Raritan, NJ, USA, ¹⁵Janssen Research & Development, Lexington, MA, USA, ¹⁶Janssen Research & Development, Spring House, PA, USA, ¹⁷Janssen Research & Development, High Wycombe, United Kingdom, ¹⁸Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands

Genomic Profiling of Young Bladder Cancer Patients Undergoing Radical Cystectomy Highlights KMT2D Enrichment
Christopher J. Magnani, MD MS, Phil, Vincent D'Andrea, MD, Kendrick Yim, MD, Zhiyu (Jason) Qian, MD, Nnamdi Onochie, BS, Benjamin V. Stone, MD, Jillian Egan, MD, Adam S. Kibel, MD, Mark A. Preston, MD, Steven L. Chang, MD MS, Matthew Mossanen, MD, Filipe L.F. Carvalho, MD PhD, Timothy N. Clinton, MD
Brigham and Women's Hospital, Boston, MA, USA

Real-World, Contemporary Efficacy of Immediate Postoperative Chemotherapy Following Transurethral Resection of Bladder Tumor in Older Adults
Andrew Amini, BS¹, Sumedh Kaul, MS², Aaron Fleishman, MPH², Agustin Perez, MD³, Ruslan Korets, MD³, Peter Chang, MD³, Andrew Wagner, MD³, Simon Kim, MD⁴, Joaquim Bellmunt, MD⁵, Nima Aghdam, MD⁶, Aria F. Olumi, MD³, Boris Gershman, MD^3
1Department of Urology, Massachusetts General Hospital, Boston, MA, USA, ²Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, ³Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA, ⁴Division of Urologic Surgery, University of Colorado Anschutz Medical Center, Aurora, CO, USA, ⁵Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA, ⁶Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA

Real-World Treatments Following Bacillus Calmette-Guérin Induction In Patients With Non-Muscle-Invasive Bladder Cancer: A Contemporary Us Claims Analysis
Min Yang, PhD, MS¹, Mirko Fillbrunn, PhD¹, Hesen Li, PhD¹, Adina Zhang, MS¹, Zhou Chen, MPH¹, Ashton Moradi, MS², Amy Guo, PhD², Ashish M. Kamat, MD^3
1Analysis Group, Inc., Boston, MA, USA, ²Ferring Pharmaceuticals Inc., Parsippany, NJ, USA, ³University of Texas MD Anderson Cancer Center, Houston, TX, USA

Efficacy Of Intravesical Nadofaragene Firadenovec-Vncg For Patients With Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: 36-Month Follow-Up From A Phase 3 Trial
Leonard G. Gomella, MD¹, Stephen A. Boorjian, MD², Vikram M. Narayan, MD³, Badrinath R. Konety, MD⁴, Viraj A. Master, MD, PhD³, Neal D. Shore, MD⁵, Ashish M. Kamat, MD⁶, Trinity J. Bivalacqua, MD, PhD⁷, Max R. Kates, MD⁸, Jeffrey S. Montgomery, MD⁹, Paul L. Crispen, MD¹⁰, Gary D. Steinberg, MD¹¹, Piyush K. Agarwal, MD¹², Anne Schuckman, MD¹³, Lawrence I. Karsh, MD, FACS¹⁴, Marc A. Bjurlin, DO, MSc, FACOS¹⁵, Gordon A. Brown, DO¹⁶, Yair Lotan, MD¹⁷, Brant A. Inman, MD¹⁸, Michael B. Williams, MD¹⁹, Michael S. Cookson, MD, FACS²⁰, Sam S. Chang, MD, MBA²¹, Eric H. Kim, MD²², Alexander I. Sankin, MD²³, Colin P N Dinney, MD^6
1Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA, ²Mayo Clinic, Rochester, MN, USA, ³Emory University School of Medicine, Atlanta, GA, USA, ⁴University of Minnesota and Allina Health Cancer Institute, Minneapolis, MN, USA, ⁵Carolina Urologic Research Center, Myrtle Beach, SC, USA, ⁶University of Texas MD Anderson Cancer Center, Houston, TX, USA, ⁷University of Pennsylvania, Philadelphia, PA, USA, ⁸The James Buchanan Brady Urological Institute and Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA, ⁹University of Michigan, Ann Arbor, MI, USA, ¹⁰University of Florida, Gainesville, FL, USA, ¹¹Rush University, Chicago, IL, USA, ¹²University of Chicago, Chicago, IL, USA, ¹³USC Institute of Urology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA, ¹⁴The Urology Center of Colorado, Denver, CO, USA, ¹⁵University of North Carolina, Chapel Hill, NC, USA, ¹⁶New Jersey Urology, Cherry Hill, NJ, USA, ¹⁷University of Texas Southwestern Medical Center, Dallas, TX, USA, ¹⁸Schulich School of Medicine & Dentistry, Western University, London, ON, Canada, ¹⁹Urology of Virginia, Virginia Beach, VA, USA, ²⁰University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA, ²¹Vanderbilt University, Nashville, TN, USA, ²²Siteman Cancer Center Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, MO, USA, ²³Montefiore Medical Center, Bronx, NY, USA

Patterns and Frequency of Synoptic Bladder & Kidney Cancer Reporting in VA Medical Centers: A Nationwide Study
Soham Kale, BS¹, Abdol Aziz Ould Ismail, MD¹, Kathryn McGonagle, BS¹, Brent Hill, MD², Jason R. Pettus, MD³, Scott L. DuVall, MD², Jeffrey P. Ferraro, MD², Florian Schroeck, MD, MS^1
1White River Junction VA Healthcare System, White River Junction, VT, USA, ²Salt Lake City VA Healthcare System, Salt Lake City, UT, USA, ³Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

Prospective Health-Related Quality of Life in Women undergoing Radical Cystectomy and Urinary Diversion
Matthew B. Clements, MD, MS¹, Kelly Pekala, MD², Daniel Sjoberg, MS², Thomas Atkinson, PhD², Guido Dalbagni, MD², Andrew Vickers, PhD², Harry Herr, MD², S Machele Donat, MD², Amy Tin, MS², Bernard Bochner, MD^2
1Lahey Hospital & Medical Center, Burlington, MA, USA, ²Memorial Sloan Kettering Cancer Center, New York, NY, USA

Evaluation of the NSQIP Surgical Risk Calculator Relative to Observed Outcomes Following Radical Cystectomy
Loren J. Smith, MD¹, Randie White, MD¹, Connor Pelletier, B.S.², Evelyn James, MPH¹, Joshua Linscott, MD, PhD³, Jeffrey Howard, MD, PhD¹, Stephen T. Ryan, MD¹, Matthew T. Hayn, MD¹, Jesse D. Sammon, D.O.^1
1Department of Urologic Surgery, Maine Medical Center, Portland, ME, USA, ²University of New England, Portland, ME, USA, ³Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA

Adjuvant Chemotherapy versus Observation for Locally Advanced Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy
Sina Monfared, MD¹, Sumedh Kaul, MS¹, Aason Fleishman, MPH¹, Agustin Perez, MD¹, Ruslan Korets, MD¹, Peter Chang, MD¹, Andrew Wagner, MD¹, Simon Kim, MD², Joaquim Bellmunt, MD, PhD¹, Nima Aghdam, MD¹, Aria Olumi, MD¹, Boris Gershman, MD^1
1Beth Israel Deaconess Medical Center, Boston, MA, USA, ²University of Colorado, Aurora, CO, USA

Association Between Time from Diagnosis to Radical Cystectomy and Oncologic Outcomes for Muscle-Invasive Urothelial Carcinoma of the Bladder
Phillip Kim, MD¹, Sumedh Kaul, MS¹, Aaron Fleishman, MPH¹, Agustin Perez, MD¹, Simon Kim, MD², Joaquim Bellmunt, MD³, Nima Aghdam, MD¹, Aria Olumi, MD¹, Peter Chang, MD¹, Andrew Wagner, MD¹, Boris Gershman, MD^1
1Beth Israel Deaconess Medical Center, Boston, MA, USA, ²University of Colorado, Aurora, CO, USA, ³Dana Farber Cancer Institute, Boston, MA, USA

Exploring Recurrence After Initial Response to UGN-101 Induction in Expanded Settings
Adam S. Feldman, MD, MPH¹, Solomon Woldu, MD², Brett Johnson, MD², Katie Murray, DO³, Hiroko Miyagi, MD⁴, Wade Sexton, MD⁴, Isamu Tachibana, MD⁵, Hristos Kaimakliotis, MD⁵, Joseph Jacob, MD⁶, Rian Dickstein, MD⁷, Jennifer Linehan, MD⁸, Alan Nieder, MD⁹, Marc Bjurlin, MD¹⁰, Daniel Hidenberg, MD¹¹, Mitchell Humprheys, MD¹¹, Saum Ghodoussipor, MD¹², Marcus Quek, MD¹³, Michael O'Donnell, MD¹⁴, Brian Eisner, MD¹, Yair Lotan, MD², Surena Matin, MD^15
1Massachusetts General Hospital, Boston, MA, USA, ²UT Southwestern, Dallas, TX, USA, ³New York University, New York, NY, USA, ⁴Moffitt Cancer Center, Tampa, FL, USA, ⁵Indiana University Medical Center, Indianapolis, IN, USA, ⁶State University of New York Upstate Medical Center, Syracuse, NY, USA, ⁷University of Maryland Medical Center, Baltimore, MD, USA, ⁸Providence Specialty Medical Group, Santa Monica, CA, USA, ⁹Mount Sinai Medical Center, Miami Beach, FL, USA, ¹⁰University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, ¹¹Mayo Clinic Cancer Center, Phoenix, AZ, USA, ¹²Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA, ¹³Loyola University Medical Center, Maywood, IL, USA, ¹⁴University of Iowa Health Care, Iowa City, IA, USA, ¹⁵University of Texas MD Anderson Cancer Center, Houston, TX, USA

STATE OF THE ART LECTURE II: AI in Healthcare: Practical Applications and Emerging Opportunities
Anobel Odisho, MD, MPH
University of California San Francisco, San Francisco, CA

Achieving and Sustaining Peak Performance: Strategies for Doctors and Their Teams
Dan Wollin, MD

Kevin Nylen
Head Coach, Boston University Men's Soccer

John Pawlowski, MD
Beth Israel Deaconess Medical Center, Boston, MA

Dan Wollin, MD
Brigham and Women's Hospital, Boston, MA

Sarah Psutka, MD
Massachusetts General Hospital, Boston, MA

SCIENTIFIC SESSION VII: Prostate Cancer II
(5 minute presentation, 3 minute discussion)
Moderators: Preston Sprenkle, MD, Matthew Mossanen, MD

Changes In Prostate Cancer Diagnostic Treatment Services Among Medicare Beneficiaries Associated With The COVID Pandemic
Vinaik Mootha Sundaresan, B.S.¹, Shayan Smani, B.S.¹, Victoria Kong, B.S.¹, Ryan Sutherland, B.S., MPH¹, Ryan Antar, B.S.², Jeffrey Weinreb, MD¹, Jay K. Pahade, MD¹, Sandeep Arora, MBBS¹, Isaac Y. Kim, MD, PhD, MBA¹, Joseph Renzulli, MD¹, Preston Sprenkle, MD¹, Christopher Filson, MD, MS³, Michael S. Leapman, MD, MHS^1
1Yale School of Medicine, New Haven, CT, USA, ²George Washington School of Medicine, Washington, DC, USA, ³Kaiser Permanente, Los Angeles, CA, USA

Changes in Serial Decipher Genomic Classifier Testing Among Patients with Prostate Cancer Managed with Active Surveillance
Lindsey T. Webb, BSME, Ghazal Khajir, MD, Darryl T. Martin, PhD, Gabriela M. Diaz, MD, Michael S. Leapman, MD, Isaac Y. Kim, MD, PhD, Preston C. Sprenkle, MD.
Yale School of Medicine, New Haven, CT, USA.

Patient Demographic Factors Associated with Radiation Cystitis Development Following Radiation for Prostate Cancer
Remington T. Lim, MD¹, Ernie Shippey, MS², Andrew P. Loehrer, MD, MPH¹, Lawrence M. Dagrosa, MD¹, Jay C. Buckey Jr., MD¹, Rachel A. Moses, MD, MPH¹.
¹Dartmouth Health, Lebanon, NH, USA, ²Vizient Center for Advanced Analytics, Chicago, IL, USA.

Treatment of Mixed Urinary Incontinence After Radical Treatment of Prostate Cancer with Botulinum Toxin: Can Surgery for Stress Incontinence be Avoided in Some Patients?
Philip Olson, MD¹, Dylan Buller, MD¹, Ilene Staff, PhD², Tara McLaughlin, PhD², Joseph Tortora, MS², Kevin Pinto, BS², Laura Olivo Valentin, BS², Richard Kershen, MD³.
¹UConn Health, Farmington, CT, USA, ²Hartford Healthcare, Hartford, CT, USA, ³Hartford Healthcare Medical Group, Hartford, CT, USA.

Body Mass Index Trajectory in Men on Active Surveillance for Prostate Cancer
Dylan Buller, MD¹, Alexander Bandin, MD², Ilene Staff, PhD², Tara McLaughlin, PhD², Joseph Tortora, MS², Kevin Pinto, BS², Joseph Wagner, MD³.
¹UConn Health, Farmington, CT, USA, ²Hartford Healthcare, Hartford, CT, USA, ³Hartford Healthcare Medical Group, Hartford, CT, USA.

Does a Positive Fluoroquinolone Resistant Rectal Swab Prior to Transrectal Prostate Biopsy Predict Post-Biopsy Infection in a Large, Multi-Center Institution?
Maximilian James Rabil, MD, Ankur U. Choksi, MD, Soum D. Lokeshwar, MD, M.B.A., Syed Rahman, MD, Preston Sprenkle, MD, Michael S. Leapman, MD, M.H.S., Joseph Renzulli, MD, Joseph Brito, III, MD.
Yale University School of Medicine, New Haven, CT, USA.

Can AI Be Useful as A Clinical Tool for Risk Stratifying Localized Prostate Cancer Patients?
Randie E. White, MD¹, Jaqueline Klepinger, BS², Jeffrey M. Howard, MD, PhD¹, Jesse D. Sammon, DO¹, Matthew H. Hayn, MD¹, Stephen T. Ryan, MD¹.
¹Maine Medical Center, PORTLAND, ME, USA, ²University of New England School of Osteopathic Medicine, Biddeford, ME, USA